UA81612C2 - Раствор для инъекций, который содержит антагонист lhrh - Google Patents
Раствор для инъекций, который содержит антагонист lhrhInfo
- Publication number
- UA81612C2 UA81612C2 UA20040503816A UA20040503816A UA81612C2 UA 81612 C2 UA81612 C2 UA 81612C2 UA 20040503816 A UA20040503816 A UA 20040503816A UA 20040503816 A UA20040503816 A UA 20040503816A UA 81612 C2 UA81612 C2 UA 81612C2
- Authority
- UA
- Ukraine
- Prior art keywords
- lhrh antagonist
- injection solution
- lhrh
- antagonist
- cetrorelix
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Водный раствор для инъекций, который содержит антагонист LHRH, содержит кроме антагониста LHRH, такого как цетрореликс, органическую, физиологически приемлемую кислоту и, по желанию, сурфактант, а также общий наполнитель. Антагонист LHRH имеет значительно улучшенную растворимость и может быть получен в более высокой концентрации и с улучшенной биодоступностью. Способность к агрегации антагониста LHRH значительно уменьшена.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10157628A DE10157628A1 (de) | 2001-11-26 | 2001-11-26 | Injektionslösung eines LHRH-Antagonisten |
PCT/EP2002/012798 WO2003045419A1 (de) | 2001-11-26 | 2002-11-15 | Injektionslösung eines lhrh-antagonisten |
Publications (1)
Publication Number | Publication Date |
---|---|
UA81612C2 true UA81612C2 (ru) | 2008-01-25 |
Family
ID=7706799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA20040503816A UA81612C2 (ru) | 2001-11-26 | 2002-11-15 | Раствор для инъекций, который содержит антагонист lhrh |
Country Status (33)
Country | Link |
---|---|
EP (1) | EP1448221B1 (ru) |
JP (1) | JP4343693B2 (ru) |
KR (1) | KR100936636B1 (ru) |
CN (1) | CN100404068C (ru) |
AR (1) | AR037424A1 (ru) |
AT (1) | ATE350050T1 (ru) |
AU (1) | AU2002365504B2 (ru) |
BR (1) | BRPI0214412B8 (ru) |
CO (1) | CO5580793A2 (ru) |
CY (1) | CY1106401T1 (ru) |
DE (2) | DE10157628A1 (ru) |
DK (1) | DK1448221T3 (ru) |
EA (1) | EA010787B1 (ru) |
ES (1) | ES2276970T3 (ru) |
GE (1) | GEP20063861B (ru) |
HK (1) | HK1073078A1 (ru) |
HR (1) | HRP20040587B1 (ru) |
HU (1) | HU230992B1 (ru) |
IL (2) | IL161894A0 (ru) |
IS (1) | IS2725B (ru) |
ME (1) | ME00499B (ru) |
MX (1) | MXPA04005018A (ru) |
NO (1) | NO333364B1 (ru) |
NZ (1) | NZ533712A (ru) |
PL (1) | PL206199B1 (ru) |
PT (1) | PT1448221E (ru) |
RS (1) | RS51408B (ru) |
RU (1) | RU2322969C2 (ru) |
SI (1) | SI1448221T1 (ru) |
TW (1) | TWI312283B (ru) |
UA (1) | UA81612C2 (ru) |
WO (1) | WO2003045419A1 (ru) |
ZA (1) | ZA200404051B (ru) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7658938B2 (en) | 1999-02-22 | 2010-02-09 | Merrion Reasearch III Limited | Solid oral dosage form containing an enhancer |
US8119159B2 (en) | 1999-02-22 | 2012-02-21 | Merrion Research Iii Limited | Solid oral dosage form containing an enhancer |
BRPI0710503A2 (pt) | 2006-04-07 | 2011-08-16 | Merrion Res Iii Ltd | uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral |
US8999383B2 (en) * | 2008-05-07 | 2015-04-07 | Merrion Research Iii Limited | Compositions of GnRH related compounds and processes of preparation |
US9089484B2 (en) | 2010-03-26 | 2015-07-28 | Merrion Research Iii Limited | Pharmaceutical compositions of selective factor Xa inhibitors for oral administration |
BR112013017169A2 (pt) | 2011-01-07 | 2016-10-04 | Merrion Res Iii Ltd | composições farmacêuticas de ferro para administração oral |
CN103690560B (zh) * | 2013-12-17 | 2016-08-17 | 辽宁海思科制药有限公司 | 一种转化糖电解质注射液药物组合物及其制备方法 |
US10265384B2 (en) | 2015-01-29 | 2019-04-23 | Novo Nordisk A/S | Tablets comprising GLP-1 agonist and enteric coating |
RU2614234C2 (ru) * | 2015-03-31 | 2017-03-23 | Федеральное государственное бюджетное учреждение науки Институт общей генетики им. Н.И. Вавилова Российской академии наук (ИОГЕН РАН) | Фармацевтическая композиция на основе 3-(4-Метилимидазол-1-ил)имидазо[1,2-b][1,2,4,5]тетразина в качестве противоопухолевого средства |
KR20210157482A (ko) * | 2017-01-30 | 2021-12-28 | 안테브 리미티드 | 적어도 하나의 gnrh 길항제를 포함하는 조성물 |
HRP20211890T1 (hr) | 2019-10-24 | 2022-03-04 | Sun Pharmaceutical Industries Ltd | Stabilan parenteralni dozni oblik cetroreliks acetata |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4800191A (en) * | 1987-07-17 | 1989-01-24 | Schally Andrew Victor | LHRH antagonists |
US5140009A (en) * | 1988-02-10 | 1992-08-18 | Tap Pharmaceuticals, Inc. | Octapeptide LHRH antagonists |
US5300492A (en) * | 1988-02-10 | 1994-04-05 | Tap Pharmaceuticals | LHRH analogs |
TR200200738T2 (tr) * | 1999-09-23 | 2002-08-21 | Zentaris Ag | Endometriyal dokunun rahim dışında çoğalması, kronik alt karın ağrısı ve fallop tüpü tıkanıklığının terapötik olarak giderilmesi. |
DE10024451A1 (de) * | 2000-05-18 | 2001-11-29 | Asta Medica Ag | Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung |
-
2001
- 2001-11-26 DE DE10157628A patent/DE10157628A1/de not_active Withdrawn
-
2002
- 2002-11-15 EA EA200400742A patent/EA010787B1/ru unknown
- 2002-11-15 ME MEP-2008-800A patent/ME00499B/me unknown
- 2002-11-15 SI SI200230505T patent/SI1448221T1/sl unknown
- 2002-11-15 CN CNB028234901A patent/CN100404068C/zh not_active Expired - Lifetime
- 2002-11-15 RU RU2004119821/15A patent/RU2322969C2/ru active
- 2002-11-15 KR KR1020047007807A patent/KR100936636B1/ko active IP Right Grant
- 2002-11-15 GE GE5568A patent/GEP20063861B/en unknown
- 2002-11-15 ES ES02790384T patent/ES2276970T3/es not_active Expired - Lifetime
- 2002-11-15 JP JP2003546920A patent/JP4343693B2/ja not_active Expired - Lifetime
- 2002-11-15 NZ NZ533712A patent/NZ533712A/en not_active IP Right Cessation
- 2002-11-15 DE DE50209193T patent/DE50209193D1/de not_active Expired - Lifetime
- 2002-11-15 DK DK02790384T patent/DK1448221T3/da active
- 2002-11-15 AT AT02790384T patent/ATE350050T1/de active
- 2002-11-15 UA UA20040503816A patent/UA81612C2/ru unknown
- 2002-11-15 EP EP02790384A patent/EP1448221B1/de not_active Expired - Lifetime
- 2002-11-15 MX MXPA04005018A patent/MXPA04005018A/es active IP Right Grant
- 2002-11-15 HU HU0401986A patent/HU230992B1/hu unknown
- 2002-11-15 PL PL369548A patent/PL206199B1/pl unknown
- 2002-11-15 PT PT02790384T patent/PT1448221E/pt unknown
- 2002-11-15 IL IL16189402A patent/IL161894A0/xx unknown
- 2002-11-15 RS YUP-449/04A patent/RS51408B/sr unknown
- 2002-11-15 WO PCT/EP2002/012798 patent/WO2003045419A1/de active IP Right Grant
- 2002-11-15 AU AU2002365504A patent/AU2002365504B2/en not_active Expired
- 2002-11-15 BR BRPI0214412A patent/BRPI0214412B8/pt not_active IP Right Cessation
- 2002-11-20 TW TW091133846A patent/TWI312283B/zh not_active IP Right Cessation
- 2002-11-25 AR ARP020104523A patent/AR037424A1/es not_active Application Discontinuation
-
2004
- 2004-05-06 IS IS7251A patent/IS2725B/is unknown
- 2004-05-10 IL IL161894A patent/IL161894A/en active IP Right Grant
- 2004-05-14 CO CO04044748A patent/CO5580793A2/es not_active Application Discontinuation
- 2004-05-25 ZA ZA2004/04051A patent/ZA200404051B/en unknown
- 2004-06-11 NO NO20042449A patent/NO333364B1/no not_active IP Right Cessation
- 2004-06-24 HR HR20040587A patent/HRP20040587B1/xx not_active IP Right Cessation
-
2005
- 2005-07-11 HK HK05105809.5A patent/HK1073078A1/xx not_active IP Right Cessation
-
2007
- 2007-03-20 CY CY20071100391T patent/CY1106401T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS44904A (en) | Injection solution comprising an lhrh antagonist | |
TW200628157A (en) | Storage stable perfusion solution for dihydropteridinones | |
DK1317419T3 (da) | Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler | |
WO2003035051A3 (en) | The use of proton sequestering agents in drug formulations | |
MXPA03011480A (es) | Una preparacion farmaceutica acuosa de cilostazol para uso parenteral. | |
PL357132A1 (en) | Stable, nasally, orally or sublingually applicable pharmaceutical preparation | |
PE20011223A1 (es) | Composicion farmaceutica que comprende pemetrexed y un antioxidante como monotioglicerol, l-cisteina y acido tioglicolico | |
UA86007C2 (ru) | Средство для стабилизирования биодизельного топлива | |
CA2412759A1 (en) | Injectable solution of an lhrh antagonist | |
IL145187A0 (en) | Echinocandin/carbohydrate complexes | |
DK1171124T4 (da) | Anthelmintpræparater | |
MXPA05008403A (es) | Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion. | |
CO5540279A2 (es) | Formulacion liofilitada de 2-metil-tieno-benzodiazepina | |
PT1543826E (pt) | Solução aquosa concentrada de ambroxol | |
ATE526988T1 (de) | Methylphenidat-lösung und relevante verabreichungs- und herstellungsverfahren | |
WO2004075834A3 (en) | Stabilized pharmaceutical compositions of safingol and methods of using the same | |
DE60135845D1 (de) | Pralmorelin-haltige nasentropfen-präparate | |
WO2006002887A8 (en) | Aqueous drink solution of indibulin (d-24851) and an organic acid | |
CN107987980A (zh) | 一种无磷环保洗衣粉 | |
EP1142878A3 (en) | Pharmaceutical compositions comprising moexipril magnesium | |
MXPA05004842A (es) | Formulacion oromucosal y proceso para su preparacion. | |
ES2166306A1 (es) | Composicion desinfectante tensioactiva. |